These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 9149182)

  • 21. Nutrition in systemic sclerosis.
    Recasens MA; Puig C; Ortiz-Santamaria V
    Reumatol Clin; 2012; 8(3):135-40. PubMed ID: 22197834
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effects of various prokinetic drugs on gastrointestinal transit times in patients with progressive systemic scleroderma].
    Folwaczny C; Läritz M; Meurer M; Endres SP; König A; Schindlbeck N
    Z Gastroenterol; 1997 Oct; 35(10):905-12. PubMed ID: 9432812
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Global improvement of systemic scleroderma under long-term administration of octreotide.
    Descamps V; Duval X; Crickx B; Bouscarat F; Coffin B; Belaich S
    Eur J Dermatol; 1999 Sep; 9(6):446-8. PubMed ID: 10491499
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of Barrett's esophagus in systemic sclerosis.
    Wipff J; Allanore Y; Soussi F; Terris B; Abitbol V; Raymond J; Chaussade S; Kahan A
    Arthritis Rheum; 2005 Sep; 52(9):2882-8. PubMed ID: 16142744
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Spontaneous pneumoperitoneum in progressive systemic sclerosis (generalized scleroderma)].
    Lang B; Meske S; Billmann P; Vaith P; Peter HH
    Z Rheumatol; 1986; 45(2):64-7. PubMed ID: 3487900
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiovascular autonomic function, autoantibodies, and esophageal motor activity in patients with systemic sclerosis and mixed connective tissue disease.
    Stacher G; Merio R; Budka C; Schneider C; Smolen J; Tappeiner G
    J Rheumatol; 2000 Mar; 27(3):692-7. PubMed ID: 10743810
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Severe gastrointestinal involvement in systemic sclerosis: report of five cases and review of the literature.
    Jaovisidha K; Csuka ME; Almagro UA; Soergel KH
    Semin Arthritis Rheum; 2005 Feb; 34(4):689-702. PubMed ID: 15692963
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recent developments in the pathophysiology and therapy of gastroesophageal reflux disease and nonerosive reflux disease.
    Tack J
    Curr Opin Gastroenterol; 2005 Jul; 21(4):454-60. PubMed ID: 15930988
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gastrointestinal manifestations of scleroderma.
    Rose S; Young MA; Reynolds JC
    Gastroenterol Clin North Am; 1998 Sep; 27(3):563-94. PubMed ID: 9891698
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of esophageal dysfunction and pulmonary function impairment in systemic sclerosis.
    Lock G; Pfeifer M; Straub RH; Zeuner M; Lang B; Schölmerich J; Holstege A
    Am J Gastroenterol; 1998 Mar; 93(3):341-5. PubMed ID: 9517636
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gastrointestinal features of scleroderma.
    Sjogren RW
    Curr Opin Rheumatol; 1996 Nov; 8(6):569-75. PubMed ID: 9018461
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systemic Sclerosis: Gastrointestinal Disease and Its Management.
    Gyger G; Baron M
    Rheum Dis Clin North Am; 2015 Aug; 41(3):459-73. PubMed ID: 26210129
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Esophageal involvement and pulmonary manifestations in systemic sclerosis.
    Marie I; Dominique S; Levesque H; Ducrotté P; Denis P; Hellot MF; Courtois H
    Arthritis Rheum; 2001 Aug; 45(4):346-54. PubMed ID: 11501722
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Gastrointestinal involvement in progressive systemic sclerosis].
    Alvarez MG; Rubaldo RE; Kerzberg EM; De Paula A; Huberman ED
    Acta Gastroenterol Latinoam; 1984; 14(4):295-302. PubMed ID: 6537704
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Involvement of the small intestine in systemic scleroderma].
    Marie I; Lévesque H; Ducrotté P; Courtois H
    Rev Med Interne; 1999 Jun; 20(6):504-13. PubMed ID: 10422142
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Systematic review: pathophysiology and management of gastrointestinal dysmotility in systemic sclerosis (scleroderma).
    Sallam H; McNearney TA; Chen JD
    Aliment Pharmacol Ther; 2006 Mar; 23(6):691-712. PubMed ID: 16556171
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Digestive complications in progressive systemic sclerosis].
    García de Castro J; Ledro D; Rubio E; Sánchez S; Benítez A; Garrido M
    Rev Esp Enferm Apar Dig; 1985 Nov; 68(5):425-7. PubMed ID: 4081268
    [No Abstract]   [Full Text] [Related]  

  • 38. Gastrointestinal Manifestations, Malnutrition, and Role of Enteral and Parenteral Nutrition in Patients With Scleroderma.
    Bharadwaj S; Tandon P; Gohel T; Corrigan ML; Coughlin KL; Shatnawei A; Chatterjee S; Kirby DF
    J Clin Gastroenterol; 2015 Aug; 49(7):559-64. PubMed ID: 25992813
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Benign persistent pneumoperitoneum in systemic sclerosis.
    Wang CL; Wang F; Wong KC; Jeyamalar R
    Singapore Med J; 1993 Dec; 34(6):563-4. PubMed ID: 8153727
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gastrointestinal manifestations of systemic sclerosis.
    Domsic R; Fasanella K; Bielefeldt K
    Dig Dis Sci; 2008 May; 53(5):1163-74. PubMed ID: 17934861
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.